Peg-ReliGrast Injection
Prescription Required
Product introduction
Peg-ReliGrast Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.
Peg-ReliGrast Injection is used after cancer treatment, if the level of white blood cells is too low, used to increase blood stem cells in the body or used after a bone marrow transplant
Peg-ReliGrast Injection is used after cancer treatment, if the level of white blood cells is too low, used to increase blood stem cells in the body or used after a bone marrow transplant
Uses of Peg-ReliGrast Injection
- Prevention of Infections after chemotherapy
Benefits of Peg-ReliGrast Injection
In Prevention of Infections after chemotherapy
Peg-ReliGrast Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.
Side effects of Peg-ReliGrast Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Peg-ReliGrast
- Bone pain
- Joint pain
- Headache
- Nausea
- Low blood platelets
- Muscle pain
- Back pain
- Pain in extremities
- Injection site pain
How to use Peg-ReliGrast Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Peg-ReliGrast Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Peg-ReliGrast Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Peg-ReliGrast Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
SAFE
Peg-ReliGrast Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Peg-ReliGrast Injection is safe to use in patients with kidney disease. No dose adjustment of Peg-ReliGrast Injection is recommended.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Peg-ReliGrast Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Peg-ReliGrast Injection
₹2919.14/Injection
Pegasta Injection
Intas Pharmaceuticals Ltd
₹10300/injection
253% costlier
Peggrafeel 6mg Injection
Dr Reddy's Laboratories Ltd
₹3010/injection
3% costlier
Pegstim Injection
Zydus Cadila
₹4339/injection
49% costlier
Pegex 6mg Injection
Emcure Pharmaceuticals Ltd
₹4173/injection
43% costlier
Lupifil P 6mg Injection
Lupin Ltd
₹4172/injection
43% costlier
Quick tips
- Peg-ReliGrast Injection reduces the risk of infection in people treated with chemotherapy.
- It is usually given as a daily injection into the tissue just under the skin or into the vein.
- You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
- Store it in the refrigerator, protect it from light, and don't shake it.
- For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
- Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
- Use caution while driving or doing anything that requires concentration as Peg-ReliGrast Injection may cause dizziness.
- Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
- Stop taking Peg-ReliGrast Injection and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
Fact Box
Chemical Class
Granulocyte Colony-Stimulating Factor
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Granulocyte-colony stimulating factor (G-CSF)
Patient concerns
User feedback
Patients taking Peg-ReliGrast Injection
Once A Month
73%
Once A Week
27%
FAQs
What is Peg-ReliGrast Injection? How is it given?
Peg-ReliGrast Injection belongs to a class of medications called colony stimulating factors. It helps reduce the chances of infections and side effects related to chemotherapy and does not directly treat cancer. It comes as a solution (liquid) to inject subcutaneously (under the skin), 24 hours after chemotherapy. It may be injected by a doctor/nurse in a hospital or you may be shown how to use injections at home
How does pegfilgrastim work?
Pegfilgrastim belongs to a class of medications called colony stimulating factors. It acts on hematopoietic cells (cells in the bone marrow that produce red blood cells, white blood cells, and platelets) to increase production of neutrophils (a type of white blood cell) in the body.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Masters SB. Agents Used in Anemias; Hematopoetic Growth Factors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 581.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1074-75.
- Pegfilgrastim. Cambridge, UK: Amgen Ltd.; 2002 [revised Sep. 2018]. [Accessed 28 Jan 2019] (online) Available from:
- Medscape. Pegfilgrastim. [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Reliance Life Sciences
Address: Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701
Country of origin: India
Lab tests offered by us
Related/Popular tests
732 people viewed this recentlyMRP
₹2919.14
Inclusive of all taxes
1.0 Injection in 1 prefilled syringe
SOLD OUT
Notify me